Quick Answer
Fatty liver (NAFLD / MASLD) is a common condition affecting roughly 1 in 3 urban Indian adults. It is caused by metabolic factors — obesity, diabetes, high lipids, sedentary lifestyle — or alcohol. Dr. Anando Sengupta diagnoses it with blood tests + FibroScan and treats it with structured lifestyle change, control of diabetes/lipids, and proven medications for NASH. Most early cases are fully reversible.
What is fatty liver?
Fatty liver disease is the accumulation of excess triglyceride within liver cells. There are two broad categories:
- NAFLD / MASLD — Non-alcoholic / metabolic dysfunction-associated steatotic liver disease (the most common form in India)
- Alcoholic liver disease — from excessive alcohol intake
The disease ranges from simple steatosis (just fat) to NASH (steatohepatitis — fat plus inflammation), fibrosis (scarring), and ultimately cirrhosis and liver cancer.
Symptoms
Most patients have no symptoms until advanced disease. When present, symptoms include:
- Fatigue, easy tiredness
- Mild discomfort or fullness in the upper right abdomen
- Brown velvety patches at the back of the neck (acanthosis nigricans — suggests insulin resistance)
- In cirrhosis: jaundice, leg swelling, abdominal distension, easy bruising, blood vomiting
Risk factors
- Obesity (BMI > 25 in Indians)
- Type 2 diabetes & pre-diabetes
- High triglycerides, low HDL
- Hypertension
- Sedentary lifestyle
- PCOS (in women)
- Hypothyroidism
- Family history of fatty liver / cirrhosis
How fatty liver is diagnosed
| Test | What it shows |
|---|---|
| Liver function test (LFT) — ALT, AST, GGT | Mild elevations — first clue to fatty liver |
| Fasting sugar, HbA1c, lipid profile | Underlying metabolic syndrome |
| Hepatitis B & C serology, autoimmune panel | Rule out other causes |
| Ultrasound abdomen | Detects moderate-severe fatty liver |
| FibroScan (transient elastography) | Quantifies fat (CAP) and stiffness/fibrosis (kPa) — best non-invasive test |
| FIB-4, APRI, NFS scores | Risk-stratify fibrosis |
| MRI-PDFF / liver biopsy | Reserved for selected cases |
Treatment
1. Weight loss — the most powerful therapy
- 5% weight loss — reduces liver fat
- 7–10% — reverses NASH and reduces fibrosis
- Aim for a slow, sustainable rate (0.5–1 kg/week)
2. Diet plan
- Mediterranean / DASH-style: vegetables, fruits, whole grains, legumes, nuts, olive oil, fish
- Reduce refined carbohydrates (white rice, maida, sugar, fruit juice, soft drinks)
- Avoid fructose-rich beverages, cold drinks, packaged snacks, fried food
- Limit red meat to 1–2 servings per week; choose lean protein
- Total alcohol abstinence is recommended in NAFLD
3. Exercise
- 150 minutes of moderate aerobic activity per week (brisk walk, cycling, swimming)
- Plus resistance/strength training 2x/week
4. Medication
- Vitamin E 800 IU/day — in non-diabetic biopsy-confirmed NASH
- Pioglitazone — diabetic NASH
- GLP-1 receptor agonists (semaglutide, tirzepatide) — significant fatty liver reduction along with weight loss
- Resmetirom (FDA-approved for NASH with fibrosis)
- Treat coexisting hypertension, dyslipidaemia and diabetes aggressively
5. Bariatric / metabolic surgery
For morbidly obese patients (BMI > 35), bariatric surgery produces durable NASH improvement and is considered when lifestyle therapy is insufficient.
Why choose Dr. Anando Sengupta for fatty liver care?
- FibroScan & advanced liver imaging access at Fortis Shalimar Bagh
- Combined gastroenterology & hepatology expertise — not just a screening report
- Integrated diet, exercise and metabolic management
- Long-term follow-up to track regression on FibroScan
Frequently Asked Questions
Fatty liver (now renamed MASLD — metabolic dysfunction-associated steatotic liver disease) is the build-up of excess fat in liver cells, usually linked to obesity, diabetes, high triglycerides or excess alcohol intake. Mild cases are reversible; advanced cases (NASH, fibrosis) can progress to cirrhosis and liver cancer.
Simple fatty liver is usually harmless on its own, but in 20–25% it progresses to non-alcoholic steatohepatitis (NASH), and in 5–10% to cirrhosis. Even before cirrhosis, fatty liver doubles the risk of heart disease and stroke.
Diagnosis combines history, blood tests (LFT, lipid profile, fasting sugar/HbA1c, fibrosis markers like FIB-4 and APRI), and imaging — ultrasound, FibroScan (liver elastography) or sometimes MRI-PDFF. Liver biopsy is reserved for select cases.
Yes — weight loss of 7–10% reverses most fatty liver and significantly improves NASH. Combined with control of diabetes, blood pressure and lipids, the disease can be halted or reversed.
A Mediterranean-style diet works best in Indian patients: high in vegetables, fruits, whole grains, legumes, nuts and olive oil; low in refined carbohydrates, sugar, fried food and red meat. Limit alcohol completely.
Currently the most evidence supports vitamin E (in non-diabetic NASH), pioglitazone (in diabetic NASH), and GLP-1 receptor agonists (semaglutide, tirzepatide) for weight reduction. Resmetirom (a thyroid receptor agonist) is now FDA-approved for NASH.
Mild fatty liver: yearly review. NASH or fibrosis: 6-monthly review with LFT, FibroScan, and ultrasound. Cirrhosis: 6-monthly ultrasound + alpha-fetoprotein for liver cancer surveillance.
Yes. Dr. Anando Sengupta consults at North Delhi Nursing Home, Ashok Vihar Phase II (Mon–Sat, 5:30–7:30 PM) — within easy reach of Model Town (3 km), GTB Nagar, Mukherjee Nagar, Wazirpur and Shastri Nagar. Morning slots and procedures (endoscopy, colonoscopy, ERCP, EUS) are at Fortis Hospital, Shalimar Bagh (~3 km from Pitampura, with cashless insurance on all major panels). Both clinics serve patients from across North Delhi.
